A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

Clinical trial NCT06405633 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06405633
Sponsor: Wave Life Sciences USA, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alpha-1 Antitrypsin Deficiency

Start date: 2024-07-19
Primary completion: 2026-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.